Assessment of Ischemia Modified Albumen in Chronic Liver Diseases
Neven Farouk Abbas, Ehsan Rizk, Azza Baiomy & Mona Arafa · International Journal of TROPICAL DISEASE & Health · 2016
Aims: Ischemia modified albumin (IMA) level is increased in ischemic conditions and in diseases such as myocardial infarction, systemic sclerosis, advanced cancer, end-stage renal disease and intrauterine disorders. The role of IMA in chronic liver diseases and its correlation wi...
Open access
Research Article
10.9734/IJTDH/2016/25293